Immunology
Hepatitis virus persistence found
Published in Hepatitis Weekly, May 12th, 2003
The finding, published online in ScienceExpress, could lead to more effective treatments for liver disease caused by hepatitis C virus, said author Michael Gale Jr., PhD, of University of Texas Southwestern Medical Center at Dallas. Gale and coauthor Stanley Lemon, MD, of University of Texas Medical Branch at Galveston, are grantees of the U.S. National Institute of Allergy and Infectious Diseases (NIAID).
"Persistent hepatitis C virus (HCV) infection is a major cause of liver disease worldwide and is the leading reason for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-05-12)
More Articles from Hepatitis Weekly
- Chronic Hepatitis B
Infection persists after clinical recovery in acute self-limited hepatitis B - Chronic Hepatitis C
Triple therapy regimens containing amantadine offer hope for HCV nonresponders - Hepatitis C Therapy
Combination therapy yields a better response in patients with HCV genotype 6 - Hepatocellular Carcinoma
TMA-HPA assay is a convenient way to determine HBV recurrence after surgery - Hepatotoxin
Chlorophyllin prevents the toxic effects of aflatoxin exposure on the liver - Immunology
Mannan-binding lectin doesn't correlate with vulnerability to hepatitis C virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
